转录性牛皮生物学测试的临床实用性发现表明,改变了医生处方行为和改善了患者的结果
Bruce E Strober1,2, Michael Bukhalo3, April W Armstrong4
1Yale University School of Medicine, New Haven, CT, USA. brucestrober30@me.com.
Dermatology and therapy
|May 11, 2025
概括
一个机器学习工具,Mind.Px,通过指导医生生物选择,显著改善了牛皮治疗结果. 这种方法提高了患者的反应,并可能降低医疗保健成本.
科学领域:
- 皮肤病学 皮肤病学
- 计算生物学 计算生物学
- 翻译医学是一种翻译医学.
背景情况:
- 牛皮的管理通常涉及生物选择的试错方法.
- 预测患者对生物药物的反应对于有效的牛皮治疗至关重要.
研究的目的:
- 评估Mind.Px的临床实用性,Mind.Px是一个机器学习工具,可以预测牛皮患者的生物反应.
- 评估Mind.Px测试结果是否影响医生的决策和改善患者的结果.
主要方法:
- 一项随机前性研究 (MATCH) 招募了210名生物先或切换牛皮的患者.
- 在生物选择之前,知情组的医生收到了Mind.Px测试结果.
- 在第4周和第12周,使用牛皮区域和严重性指数 (PASI) 评估了患者的结局.
主要成果:
- 与标准护理 (62.9%) 相比,医生对Mind.Px结果的一致性显著更高 (92.3%).
- 医生使用Mind.Px的患者在12周 (p=5.4×10−4) 和4周 (p=0.01) 实现PASI75的比率显著更高.
结论:
- Mind.Px通过指导生物选择和改善患者在牛皮管理中的结果来证明临床实用性.
- 该工具尽量减少试错治疗,为医生,患者和医疗保健系统提供好处.
- 改善患者的治疗结果可能会导致潜在的医疗保健成本节省.
更多相关视频
10:35A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction
Published on: April 5, 2018
10.3K
02:28Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
312
相关概念视频
Changes in Skin Color: Clinical Perspectives
The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Bioequivalence of Drugs: Drugs with Multiple Indications
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each indication due to...
Rapid Identification of Pathogens
MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...
